Extra-Gonadal and Non-Canonical Effects of FSH in Males
Pharmaceuticals · 30.05.2023 · 16 (6) · 813
DOI: 10.3390/ph16060813 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.05.2023. Verfasst von Matteo Spaziani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recombinant follicle-stimulating hormone (FSH) is commonly used for the treatment of female infertility and is increasingly being used in males as well, as recommended by notable guidelines. FSH is composed of an α subunit, shared with other hormones, and a β subunit, which confers specificity of biological action by interacting with its surface receptor (FSHR), predominantly located in granulosa and Sertoli cells. However, FSHRs also exist in extra-gonadal tissues, indicating potential effects beyond male fertility. Emerging evidence suggests that FSH may have extra-gonadal effects, including on bone metabolism, where it appears to stimulate bone resorption by binding to specific receptors on osteoclasts. Additionally, higher FSH levels have been associated with worse metabolic and cardiovascular outcomes, suggesting a possible impact on the cardiovascular system. FSH has also been implicated in immune response modulation, as FSHRs are expressed on immune cells and may influence inflammatory response. Furthermore, there is growing interest in the role of FSH in prostate cancer progression. This paper aims to provide a comprehensive analysis of the literature on the extra-gonadal effects of FSH in men, with a focus on the often-conflicting results reported in this field. Despite the contradictory findings, the potential for future development in this area is substantial, and further research is needed to elucidate the mechanisms underlying these effects and their clinical implications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine, Sapienza University of Rome, 00185 Roma, Italy.
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, 00185 Rome, Italy.
- Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Roma, Italy.
ORCID-Profile: Francesco Carlomagno, Marta Tenuta, Franz Sesti, Davide Ferrari, Marco Fiore, Carla Petrella, Luigi Tarani, Carlotta Pozza
Zitieren
APA
Spaziani, M., Carlomagno, F., Tenuta, M., Sesti, F., Angelini, F., Bonaventura, I., Ferrari, D., Tarantino, C., Fiore, M., Petrella, C., Tarani, L., Gianfrilli, D., & Pozza, C. (2023). Extra-Gonadal and Non-Canonical Effects of FSH in Males. Pharmaceuticals, 16(6), 813. https://doi.org/10.3390/ph16060813
Vancouver
Spaziani M, Carlomagno F, Tenuta M, Sesti F, Angelini F, Bonaventura I, et al. Extra-Gonadal and Non-Canonical Effects of FSH in Males. Pharmaceuticals. 2023;16(6):813. doi:10.3390/ph16060813
BibTeX
@article{Spaziani2023,
author = {Spaziani, Matteo and Carlomagno, Francesco and Tenuta, Marta and Sesti, Franz and Angelini, Francesco and Bonaventura, Ilaria and Ferrari, Davide and Tarantino, Chiara and Fiore, Marco and Petrella, Carla and Tarani, Luigi and Gianfrilli, Daniele and Pozza, Carlotta},
title = {Extra-Gonadal and Non-Canonical Effects of FSH in Males},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {6},
pages = {813},
doi = {10.3390/ph16060813}
}
EUVIMED